New England Biolabs Acquires Fluorogenics Limited
May 10, 2021
New England Biolabs (NEB) has agreed to acquire Fluorogenics Limited (FGL), a UK-based lyophilization R&D and ISO 13485-certified service provider. FGL will become a wholly owned subsidiary of NEB as NEB integrates lyophilization capabilities into its OEM and Customized Solutions offering to better serve molecular and point-of-care diagnostics customers.
- Buyers
- New England Biolabs, Inc.
- Targets
- Fluorogenics Limited
- Industry
- Biotechnology
- Location
- Wiltshire, United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Illumina Acquires Fluent BioSciences
July 9, 2024
Biotechnology
Illumina, Inc. has acquired Fluent BioSciences to integrate Fluent's PIPseq single-cell technology into Illumina's product portfolio and accelerate its multiomics capabilities. The acquisition, which closed July 9, 2024 and was funded with cash on hand, brings Fluent's accessible, scalable single-cell chemistry and the Fluent team into Illumina to expand end-to-end single-cell solutions for research and applied customers.
-
Vector Laboratories Acquires Click Chemistry Tools and Fluoroprobes
March 6, 2023
Biotechnology
Vector Laboratories, a portfolio company of Thompson Street Capital Partners, has acquired Click Chemistry Tools (Scottsdale, AZ) and Fluoroprobes to expand its manufacturing, bioconjugation and labeling capabilities. The add-on acquisitions, with terms undisclosed, are intended to accelerate commercialization of protein detection technologies and increase security of supply for biopharma, diagnostics and life-science customers.
-
Fulgent Genetics Acquires Fulgent Pharma
November 7, 2022
Biotechnology
Fulgent Genetics completed the acquisition of Fulgent Pharma Holdings for approximately $100 million in a combination of cash and Fulgent common stock. The deal integrates Fulgent Pharma’s nanoencapsulation drug-delivery platform and clinical-stage oncology pipeline with Fulgent Genetics’ diagnostics capabilities to create a vertically integrated precision-medicine offering focused on cancer.
-
Eurofins Scientific Acquires Genetic Lab Co.,Ltd. (G Lab) in Japan
December 10, 2021
Healthcare Services
Eurofins Scientific has entered into a share purchase agreement to acquire Genetic Lab Co.,Ltd. (“G Lab”), a molecular biology-based testing provider in Japan. The acquisition is intended to strengthen Eurofins’ expansion in Asia and enhance its clinical and genetic testing capabilities, including COVID-19 PCR testing and biomarker development support for drug discovery and companion drugs.
-
Inhance Technologies Acquires Fluor Technik System GmbH
October 16, 2019
Manufacturing
Inhance Technologies, a portfolio company of Aurora Capital Partners, has acquired Fluor Technik System GmbH (FTS), a Lauterbach-based provider of post-mold fluorination and plastic surface modification solutions. The acquisition gives Inhance a strategic European presence and expands its fluorination capabilities to better serve customers across medical devices, consumer products, automotive and other end markets.
-
Bacharach (FFL Partners) Acquires Neutronics
July 3, 2018
Manufacturing
Bacharach, a portfolio company of FFL Partners, has acquired Neutronics, Inc., a provider of refrigerant and gas analysis instrumentation. BDO Capital served as exclusive financial advisor to Neutronics and worked with the company's shareholders and management through the sale process; the acquisition expands Bacharach/FFL's capabilities in gas/refrigerant analysis for HVAC-R, automotive and semiconductor end markets.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.